NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing Applied Spectral Imaging's GenASIs Scan & Analysis automated gene scanner as an aid in ALK gene analysis for lung cancer therapy selection, ASI said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.